<DOC>
	<DOCNO>NCT00838149</DOCNO>
	<brief_summary>The purpose study see whether enteral glutamine supplementation improve intestinal permeability small intestinal morphology patient Crohn 's disease .</brief_summary>
	<brief_title>Effect Glutamine Intestinal Permeability Crohn 's Disease</brief_title>
	<detailed_description>Glutamine abundant amino acid body constitute 50 % 60 % total free amino acid pool muscle 20 % plasma . Recently reclassify conditionally essential amino acid due body 's inability synthesize sufficient amount stressful condition like trauma sepsis . It essential fuel fibroblast , lymphocytes enterocytes . It play important role nitrogen balance integral role glucose regulation also acid base homeostasis . It essential ingredient glutathione , important antioxidant . During last decade number experimental clinical study , use enteral parenteral glutamine supplement , show beneficial role condition like sepsis infection , elective surgery accidental injury , catabolic state , fetal critically ill low birth weight neonates cancer . A experimental clinical study also show positive role inflammatory bowel disease , attribute effect glutamine intestinal permeability , growth enterocytes , enhancement gut immunity glutathione synthesis . So far hardly well-planned randomized trial enteral glutamine supplement Crohn 's disease . Hence study plan evaluate effect enteral glutamine supplement structure function intestine patient Crohn 's disease . Diagnosed case Crohn 's Disease attend Gastroenterology OPD admit ward AIIMS randomize two group , glutamine whey protein group . The parameter intestinal function structure test , permeability , villous height , plasma glutamine D-xylose absorption base line end intervention . As per available data improvement expect structure function intestine , important contribution management chronic disease .</detailed_description>
	<mesh_term>Crohn Disease</mesh_term>
	<criteria>All consecutive patient Crohn 's disease remission phase abnormal intestinal permeability ( IP ) Patients active phase disease i.e . CDAI score &gt; 150 Patients normal intestinal permeability i.e . LMR &lt; 0.0373 Patients already take high protein nutritional supplement Patients associated systemic disease like chronic liver disease , chronic kidney disease , diabetes mellitus , malignancy Patients special physiologic condition i.e. , pregnancy lactation . Patients lesser 15 year ( pediatric group ) 60 year age ( elderly patient )</criteria>
	<gender>All</gender>
	<minimum_age>15 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>February 2009</verification_date>
</DOC>